"At HonorHealth, our team members and physicians are focused on doing what’s right for our community. That is why we look more closely, go beyond the surface and see every dimension in everything we do, providing a level of care that defies the expected. And, we promise to not only live up to our name, but also follow through with action: Delivering care with integrity, respect and dedication to you."

During the past decade, Scottsdale Healthcare Shea conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scottsdale Healthcare Shea" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Aegera Therapeutics" with 1 trials sponsored, "HonorHealth Research Institute" with 1 trials sponsored and "Infraredx" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scottsdale Healthcare Shea" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Scottsdale Healthcare Shea" are "Coronary Artery Disease" (3 trials), "Myocardial Infarction" (2 trials), "Stroke" (2 trials), "Advanced Solid Tumors" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Scottsdale Healthcare Shea" in a lesser frequency.

Most popular intervention types in "Scottsdale Healthcare Shea" are "Device" (11 trials), "Drug" (7 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coronary PCI guided by Angiography" (2 trials), "Coronary PCI guided by OCT" (2 trials), "Tendyne Mitral Valve System" (2 trials), "AEG35156" (1 trials) and "AMPLATZER™ PFO Occluder" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scottsdale Healthcare Shea" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Scottsdale Healthcare Shea". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Scottsdale Healthcare Shea, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Scottsdale Healthcare Shea, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".